Home » Topics » Regulatory » Patents

Patents
RSS

Novartis discovers compounds with anti-PDE IV and other actions

July 8, 1997

AHP discloses agents useful for disorders of the dopaminergic system

July 8, 1997

Inhibitors of tyrosine kinase disclosed by Pharmacia & Upjohn

July 7, 1997

MMP/TNF-alpha inhibitors from Abbott

July 7, 1997

HIV protease inhibitors described by Searle

July 7, 1997

Synaptic and Merck & Co. prepare selective human alpha1A-adrenoceptor antagonists

July 7, 1997

Selective dopamine autoreceptor agonists prepared by American Home Products

July 7, 1997

Antimalarial agents from Roche

July 7, 1997

SmithKline Beecham and Nycomed disclose hemoregulatory compounds

July 7, 1997

Pharmacia & Upjohn discloses agents for diabetes

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...